TaiFu Biopharmaceutical 2025 Q4 Financial Report
NQ Score
55/100
N1 Content Completeness
3
AI Summary (NQ-processed)
TaiFu Biopharmaceutical (Company Code: 6541) reported a basic EPS of -6.13 NTD for Q4 2025. The company's operating revenue was 401 million NTD, with a net loss after tax of 1.5 billion NTD.
AI analysis data is not yet available.